The UCL Technology Fund (UCLTF), which provides funding and support for UCL’s most transformative innovations, has approved an investment of up to £1m in Profes [...]
About emmaadminThis author has not yet filled in any details.
So far emmaadmin has created 304 blog entries.
A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer’s disease, according to scientists at UCL. In tria [...]
Two-dimensional (2D) nanomaterials have been made by dissolving layered materials in liquids, according to new UCL-led research. The liquids can be used to appl [...]
Sir Simon Campbell CBE FRS FMedSci was welcomed by staff, and guests when he officially opened The Domainex Medicines Research Centre on Friday 11th November. T [...]
A breakthrough treatment for liver disease could offer hope to the millions worldwide who suffer from the illness and reduce the annual UK toll of 13,000 deaths [...]
During today’s Nature Webinar, Professor Julie Daniels of UCL Institute of Ophthalmology explained how her laboratory has successfully developed multilayer corn [...]
UCLB spin-out companies will be at the heart of a new £1 billion life sciences company which has been created by three major investors in cancer research and ot [...]
Insurers now have an easy way to access, visualise, and analyse European windstorm data from UCLB spinout company EuroTempest, to help them proactively manage r [...]
MediaGamma launches next generation artificial intelligence product set to reshape the ad tech marketemmaadmin2017-08-03T09:52:11+01:00
MediaGamma, a spinout from UCL’s Computer Science department, which is supported by UCL Business, has announced the launch of a new audience prediction product, [...]
BBC technology correspondant Rory Cellan-Jones, reports on Chirp's new deal with Activision, one of the world's biggest games businesses. Activision is set to r [...]